- Home
- WSBF vs PALI Comparison
WSBF vs PALI Comparison
Compare WSBF & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WSBF | PALI |
|---|---|---|
| Founded | 1921 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 312.7M | 311.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WSBF | PALI |
|---|---|---|
| Price | $17.50 | $1.81 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 44.0K | ★ 6.3M |
| Earning Date | 01-26-2026 | 11-10-2025 |
| Dividend Yield | ★ 3.42% | N/A |
| EPS Growth | ★ 87.32 | N/A |
| EPS | ★ 1.32 | N/A |
| Revenue | ★ $137,060,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.26 | ★ N/A |
| Revenue Growth | ★ 2.87 | N/A |
| 52 Week Low | $11.61 | $0.53 |
| 52 Week High | $18.61 | $2.64 |
Technical Indicators
Market Signals| Indicator | WSBF | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 59.01 | 46.47 |
| Support Level | $17.24 | $1.64 |
| Resistance Level | $18.61 | $1.96 |
| Average True Range (ATR) | 0.44 | 0.16 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 52.09 | 38.14 |
Price Performance
Historical ComparisonAbout WSBF Waterstone Financial Inc. (MD)
Waterstone Financial Inc is a holding company. Through its subsidiaries, it operates in two reportable segments: Community Banking and Mortgage Banking. The Community Banking segment provides consumer and business banking products and services to customers, which include various types of loans, deposits, and personal investment services. The Mortgage Banking segment involves residential mortgage loans for the primary purpose of sale in the secondary market. The vast majority of its revenue comes from the Community Banking segment.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.